Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 166,095 shares at $100.40 ($16.8M) on 2019-08-16, disclosed to the SEC on 2019-08-16.
Open-market sale of $16.8M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.40 | 22,127 | $2.2M | 13.2% |
| 2 | $101.18 | 133,534 | $13.5M | 80.5% |
| 3 | $101.66 | 10,434 | $1.1M | 6.3% |
| Total | $101.11 avg | 166,095 | $16.8M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |